The LUVEN screening test method created by scientist of our company detects cancer at its early stages with the accuracy of up to 96% only comparable to biopsy. None of the existing diagnostic techniques has such a high diagnostic accuracy. The LUVEN technology allows diagnosing the disease at its early stages , thus, giving a chance to thousands of people to prevent its further development.

4.3
See rating distribution
ICO rating reflects the amount of information available about a project and does not indicate its quality. Therefore, ICO rating must not be taken as investment advice

Closed 1 year ago

Pre-Sale 12/12/2017 noon - 12/29/2017 midnight
Token Sale 01/15/2018 noon - 02/28/2018 midnight
Country Ukraine
Type ICO
L
Lina Lisitsa
SMO/SMM MANAGER
NOT VERIFIED
A
Alexander Danilchenko
CEO
NOT VERIFIED
N
Nikolay Shchukin
POSTGRADUATE STUDENT OF CHAIR FOR BIOMEDICAL ENGINEERING
NOT VERIFIED
A
Aleksander Shchukin
NUCLEAR PHYSICIAN
NOT VERIFIED
G
Galina Shchukina
GENETICIST & CYTOLOGIST
NOT VERIFIED
G
Grigory Evglevskiy
CTO
NOT VERIFIED
A
Alexander Kamensky
PRINCIPAL SOFTWARE ENGINEER
NOT VERIFIED
Y
Yana Ivchenko
PR MANAGER
NOT VERIFIED
4.3
See rating distribution
ICO rating reflects the amount of information available about a project and does not indicate its quality. Therefore, ICO rating must not be taken as investment advice

Closed 1 year ago

Pre-Sale 12/12/2017 noon - 12/29/2017 midnight
Token Sale 01/15/2018 noon - 02/28/2018 midnight
Country Ukraine
Type ICO

Financial information

Platform Ethereum
Total raised 26,350 USD

Interest

Alexa rank 17,374,300 th
Telegram participants 1,220
Twitter followers 2,094
Promotional video views 1,443
Similar icos
Disclaimer

TrackICO does not encourage investing in any ICOs published on the platform. Make sure to do your own thorough research before putting money into Initial Coin Offerings. All content on TrackICO is meant to be used for information purposes only, and should not be taken as financial or investment advice.